Physician profile
Daniel Dubose
NPI 1548649296
$2,235.81
in general payments reported to CMS, 2019-2025
16 companies · $101 in 2025
The $101 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $843 · 2020: $541 · 2021: $550 · 2022: $128 · 2023: $38.46 · 2024: $33.96 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $173.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $966.84 | 2019-2021 | |
| Abbott Laboratories | $327.91 | 2021-2025 | Proclaim |
| Medtronic USA, INC. | $183.38 | 2019-2020 | |
| Boston Scientific Corporation | $156.73 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Vertiflex, INC. | $149.04 | 2019 | |
| Si-Bone, INC. | $133.14 | 2020 | |
| Painteq LLC | $66.14 | 2021-2022 | |
| Biotronik Nro, INC. | $53.26 | 2025 | Prospera |
| Horizon Therapeutics Plc | $46.97 | 2021 | |
| Mml US, INC. | $38.30 | 2023-2025 | Reactiv8 |
| Nalu Medical, INC. | $24.85 | 2022 | |
| Pylant Medical | $20.21 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $19.70 | 2022 | |
| Stimwave Technologies Incorporated | $18.63 | 2022 | |
| Abbvie INC. | $16.46 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $14.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Dubose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.